The suppression of stimulator of interferon genes (STING), which is an endoplasmic reticulum membrane protein involved in innate immune response, has been identified as the central theme of remdesivir-mediated blockade of NAFLD progression [34]. Here, STING1 is linked to metabolic dysfunction-associated steatotic liver disease.